Last month, NHS England announced its multi-billion pound, five-year GP funding deal, which chief executive Simon Stevens called "unarguably the biggest boost to primary care in more than 15 years".
In the "first major pillaring" of the long-awaited NHS long-term plan – itself published a few weeks before the new GP contract – the commissioning body announced it will make more than 20,000 roles available across five groups working in primary care – including "clinical" pharmacists. This will be paid for by an increase in core general practice funding of £4.5 billion for the next five years.
But what will these changes – and the additional funding they will bring – mean for the community pharmacy sector?
Click on the bullet